FDA NDC Directory · JSON-LD · Markdown

FLUBLOK TRIVALENT NORTHERN HEMISPHERE

NDC 49281-726 · VACCINE · INJECTION

Generic nameINFLUENZA A VIRUS A/Missouri/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/Darwin/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/Pennsylvania/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN
Labeler / ManufacturerSanofi Vaccines US Inc.
Marketing categoryBiologic License Application · App BLA125285
Dosage form / routeINJECTION · INTRAMUSCULAR
Active ingredientsINFLUENZA A VIRUS A/MISSOURI/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN (45 ug/.5mL)
INFLUENZA A VIRUS A/DARWIN/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN (45 ug/.5mL)
INFLUENZA B VIRUS B/PENNSYLVANIA/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN (45 ug/.5mL)
Marketing started20260702
Marketing ended20270630
Package count1

External sources

Source: openFDA. Public-domain (CC0).